Zeitschriftenaufsatz | 2010

The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.

Autor:in

Wolfesberger, B; Tonar, Z; Gerner, W; Skalicky, M; Heiduschka, G; Egerbacher, M; Thalhammer, J G; Walter, I;

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Journal

Schlagwörter

Animals; Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use*; Apoptosis/drug effects*; Benzenesulfonates/pharmacology; Benzenesulfonates/therapeutic use*; Bone Neoplasms/drug therapy; Bone Neoplasms/enzymology; Bone Neoplasms/veterinary*; Caspase 3/metabolism; Cell Count; Cell Line, Tumor; Dog Diseases/drug therapy*; Dog Diseases/enzymology; Dogs; Flow Cytometry; Ki-67 Antigen/metabolism; Microscopy, Electron, Transmission; Niacinamide/analogs & derivatives; Osteosarcoma/drug therapy; Osteosarcoma/enzymology; Osteosarcoma/veterinary*; Phenylurea Compounds; Protein-Tyrosine Kinases/antagonists & inhibitors*; Pyridines/pharmacology; Pyridines/therapeutic use*;

Dokumententyp

Originalarbeit

ISSN/eISSN

0034-5288 -

DOI

10.1016/j.rvsc.2009.06.009

WoS ID

WOS:000273916000018

PubMed ID

19665156